Drug Retail
featured
CAMP HILL, Pa.-- The flu helped Rite Aid Corp. sales in established stores rise slightly in January, although generic drugs continued to hurt the drugstore chain's pharmacy sales.
» Read MoreMore
-
CAMP HILL, Pa.-- The flu helped Rite Aid Corp. sales in established stores rise slightly in January, although generic drugs continued to hurt the drugstore chain's pharmacy sales.
-
Washington State's liquor control board is seeking a marijuana consultant to help forge ahead regulation for its newly legalized substance. Steve Fox, director of government relations with the Marijuana Policy Project, offers insight.
-
Opko Health chairman and CEO Dr. Phillip Frost, offers insight on his company's acquisition of Cytochromas, its partnerships with companies like Bristol-Meyers Squibb, and where the company is headed this year.
-
Watson Pharmaceuticals has merged with Actavis, and will now trade on the NYSE under ticker symbol ACT. Its president & CEO Paul Bisaro, discusses the U.S. economy and the generic drug industry.
-
The world is gearing up for Lance Armstrong's big interview tonight with Oprah Winfrey. Robbie Vorhaus, founder & CEO of Vorhaus Communications, weighs in.
-
The relative prospects for shares of Pfizer and Johnson & Johnson are debated by a fundamental analyst and a technical analyst. (2:58)
-
In the wake of Johnson & Johnson's manufacturing problems, CVS has changed the way it stocks Tylenol, reports CNBC's Bertha Coombs.
-
NBC's Anne Thompson reports Lance Armstrong confessed to using performance enhancing drugs in an interview with Oprah Winfrey; and CNBC's Scott Cohn reports Armstrong has now complied with the subpoena for all of his medical records.
-
Could a widely used MS treatment work on other diseases?
-
The iShare Biotech ETF is up 32 percent over the past year. Jean-Jacques Bienaime, BioMarin Pharmaceutical CEO, discusses the reason behind his company behind up 24.9 percent in the last 3 months.
-
Retailers should be buzzing right now with holiday gift card redemptions. But, there's early evidence retailers aren't getting much of a boost from gift cards this year, according to NBG Market Analyst Brian Sozzi.
-
Onyx Pharmaceuticals CEO Dr. Anthony Coles discusses his company's thyroid cancer drug and its blood cancer drug and its partnership with Bayer.
-
NPS Pharmaceuticals CEO Dr. Francois Nader discusses the approval of its short bowel syndrome drug Gattex, and what's next for the company.
-
The latest batch of retail sales reports shed light on who the retail winners are right now.
-
The American Psychiatric Association now says it's okay to use antidepressants for someone who is grieving over a recently lost loved one. Beverly Hills Psychiatrist Dr. Carole Lieberman, offers insight.
-
Dec 21- Walgreen Co posted an unexpected decline in quarterly profit on Friday as the largest U.S. drugstore chain works on winning back shoppers after a major contract dispute with Express Scripts Holding Co..
-
Dec 21- Walgreen Co posted a lower quarterly profit on Friday as the largest U.S. drugstore chain works on winning back shoppers after losing many of them earlier this year during a major contract dispute with Express Scripts Holding Co..
-
Dec 21- Walgreen Co posted an unexpected decline in quarterly profit on Friday as the largest U.S. drugstore chain worked on winning back former customers and changed how it accounts for its first international acquisition.
-
The Supreme Court is taking on the "pay for delay" method used by big pharmaceutical companies, and pilots at American Airlines voted to ratify a new contract, reports CNBC's Brian Shactman.
-
CNBC's Jane Wells reports Washington's new state law that makes it legal to smoke pot, is more complicated than it sounds, and Allen St. Pierre, NORML executive director, weighs in on the financial benefits of reforming marijuana laws.